Back to results
US 2017/0362298 A1Published application
Enhanced affinity t cell receptors and methods for making the same
AssigneeFred Hutchinson Cancer Research Center
InventorsThomas M. SCHMITT, Philip D. GREENBERG
Life of this patent
Estimating the term…
Abstract
The present disclosure provides methods for generating enhanced affinity T cell receptors by agonist selection of hematopoietic progenitor cells expressing an antigen specific TCRα cultured with stromal cells expressing Delta-like-1 or Delta-like-4, compositions prepared from such methods, and uses of thereof.
Claims1
A method for generating an enhanced affinity T cell receptor (TCR), comprising:
- a. contacting hematopoietic progenitor cells with stromal cells and a peptide antigen, under conditions and for a time sufficient to induce differentiation of hematopoietic progenitor cells into DN TCRαβ+ thymocytes, b. isolating nucleic acid sequences encoding the various TCRβ chains from the DN TCRαβ+ thymocytes and introducing the nucleic acid sequences encoding the TCRβ chains into cells that are capable of expressing a TCR on the cell surface and comprise the nucleic acid sequence encoding the TCRα chain from step (a);
- and
- c. identifying enhanced affinity TCR,
- wherein the hematopoietic progenitor cells comprise a non-endogenous nucleic acid sequence encoding a TCRα chain from a parent TCR specific for the peptide antigen, and
- wherein the stromal cells comprise a non-endogenous nucleic acid sequence encoding Delta-like-1 or Delta-like-4 and a nucleic acid sequence encoding an MHC molecule;
2 more elements
Dependencies are inferred from the claim text.